NanoSyrinx appoints Jane Dancer to the Board as a new NED

NanoSyrinx is delighted to announce that Jane Dancer has agreed to join the Board and is bringing with her a wealth of business development and strategic knowledge for driving value from platform companies.

Jane is a well-known figure in the sector, having served as CBO at F-Star, Cambridge Antibody Technologies, as well as VP for Cellzome, and much more besides!

Jane will be instrumental in supporting the team as we build partnerships over the course of the next couple of years and the team is excited to be working together.

Full press release details can be found here:

Follow us on social media to stay up to date!


Read more news

NanoSyrinx highlighted in Cell Trends

Our CEO Joe Healey was recently invited to write a piece for Cell Trends’ “Industry Highlights”, which is now available online here. These articles offer short reads about up and coming companies and technologies that are making waves in the industry. NanoSyrinx is delighted to have had the opportunity to tell our story. The article […]

Read more

NanoSyrinx CEO Joe Healey appointed to DSIT’s Engineering Biology Steering Group

In 2023, the UK Government published the “National Vision for Engineering Biology”. The report highlighted the ambitions of the UK to be a world leader in the Engineering Biology (a.k.a. Synthetic Biology) sector, and described how £2BN would be put to work over the next decade, cementing the UK’s position at the front of the […]

Read more

NanoSyrinx at Number 10

Our CEO Joe Healey was invited to Number 10 this week, to discuss the future of Engineering Biology in the UK as part of a networking and investment breakfast. Synthetic biology or “Engineering Biology” has been highlighted as one of the five key technology areas for the UK’s future economy. Understanding how best to incubate, […]

Read more